Loading…
HLA genotyping as first-line screening tool for coeliac disease in children with juvenile idiopathic arthritis
ObjectivesCoeliac disease (CD) and juvenile idiopathic arthritis (JIA) often coexist. This association warrants assessment for CD in patients with JIA. We evaluated the clinical relevance and cost-effectiveness of human leucocyte antigen (HLA) genotyping in first-line screening for development of CD...
Saved in:
Published in: | Archives of disease in childhood 2017-07, Vol.102 (7), p.607-611 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-b458t-747d6e3e6120be635377cfa9c7ea69ffefee44cd839176b7975bdcd13d5a665d3 |
---|---|
cites | cdi_FETCH-LOGICAL-b458t-747d6e3e6120be635377cfa9c7ea69ffefee44cd839176b7975bdcd13d5a665d3 |
container_end_page | 611 |
container_issue | 7 |
container_start_page | 607 |
container_title | Archives of disease in childhood |
container_volume | 102 |
creator | Skrabl-Baumgartner, Andrea Christine Hauer, Almuthe Erwa, Wolfgang Jahnel, Jörg |
description | ObjectivesCoeliac disease (CD) and juvenile idiopathic arthritis (JIA) often coexist. This association warrants assessment for CD in patients with JIA. We evaluated the clinical relevance and cost-effectiveness of human leucocyte antigen (HLA) genotyping in first-line screening for development of CD in children with JIA.Patients and interventions95 patients with JIA were screened for CD using CD-specific antibodies. In case of positivity, a small intestinal biopsy was performed to confirm diagnosis. In addition, HLA genotyping was performed. 110 age-matched and sex-matched Caucasian children from the same geographical area served as controls.ResultsCD was diagnosed in 4 of 95 patients with JIA (4.2%), a rate significantly higher compared with controls (p |
doi_str_mv | 10.1136/archdischild-2016-311544 |
format | article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1916378157</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A506919505</galeid><sourcerecordid>A506919505</sourcerecordid><originalsourceid>FETCH-LOGICAL-b458t-747d6e3e6120be635377cfa9c7ea69ffefee44cd839176b7975bdcd13d5a665d3</originalsourceid><addsrcrecordid>eNqNkU-P0zAQxSMEYrsLXwFZ4sIlix3_zbGqgEWqtBc4W44zaVy5drEdYL89LlkQ4gInS-Pfm3kzr2kQwbeEUPHWJDuPLtvZ-bHtMBEtJYQz9qTZECZULTH2tNlgjGnbK6WumuucjxiTTin6vLnqVEc7xtWmCXf7LTpAiOXh7MIBmYwml3JpvQuAsk0A4VIvMXo0xYRsBO-MRXU8mAzIBfTTRoKAvrkyo-PytUp8_RldPJsyO4tMKnNyxeUXzbPJ-AwvH9-b5vP7d592d-3-_sPH3XbfDtVVaSWTowAKgnR4AEE5ldJOprcSjOinCSYAxuyoaE-kGGQv-TDakdCRGyH4SG-aN2vfc4pfFshFn-q5wHsTIC5Zk54IKhXh8t-okh2XUkla0dd_oce4pFAXuTSsB8U9w5VqV-pgPGgXbAwFvhcbvYcD6Lrn7l5vORY96TnmlVcrb1PMOcGkz8mdTHrQBOtL3PrPuPUlbr3GXaWvHg0twwnG38Jf-VaArsBwOv5_2x_657p3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1912450940</pqid></control><display><type>article</type><title>HLA genotyping as first-line screening tool for coeliac disease in children with juvenile idiopathic arthritis</title><source>Social Science Premium Collection</source><source>Education Collection</source><creator>Skrabl-Baumgartner, Andrea ; Christine Hauer, Almuthe ; Erwa, Wolfgang ; Jahnel, Jörg</creator><creatorcontrib>Skrabl-Baumgartner, Andrea ; Christine Hauer, Almuthe ; Erwa, Wolfgang ; Jahnel, Jörg</creatorcontrib><description>ObjectivesCoeliac disease (CD) and juvenile idiopathic arthritis (JIA) often coexist. This association warrants assessment for CD in patients with JIA. We evaluated the clinical relevance and cost-effectiveness of human leucocyte antigen (HLA) genotyping in first-line screening for development of CD in children with JIA.Patients and interventions95 patients with JIA were screened for CD using CD-specific antibodies. In case of positivity, a small intestinal biopsy was performed to confirm diagnosis. In addition, HLA genotyping was performed. 110 age-matched and sex-matched Caucasian children from the same geographical area served as controls.ResultsCD was diagnosed in 4 of 95 patients with JIA (4.2%), a rate significantly higher compared with controls (p<0.02) and 14 times higher than in the general population. Twenty-six patients (27.4%) had one of the variants of the risk genotypes. All four patients diagnosed with CD had a HLA-DQ2.5 genotype: one was homozygote, the remainder heterozygote. Twenty-two patients are, judging by their HLA genotypes, at risk of developing CD and require repeated serological screening. None of the 69 patients without HLA-DQ2/DQ8 genotypes had CD-specific antibodies. Screening with HLA genotyping becomes cheaper than screening without after the second determination.ConclusionsIn our cohort of patients with JIA, lack of HLA-DQ2/DQ8 genotypes identified a majority not at risk of CD in whom repeated serological testing is unnecessary. Genotyping is nowadays the most efficient and cost-effective way to screen for CD risk in JIA.</description><identifier>ISSN: 0003-9888</identifier><identifier>EISSN: 1468-2044</identifier><identifier>DOI: 10.1136/archdischild-2016-311544</identifier><identifier>PMID: 28232458</identifier><language>eng</language><publisher>England: BMJ Publishing Group Ltd</publisher><subject>Adolescent ; Age of Onset ; Antibodies ; Antigens ; Arthritis ; Arthritis, Juvenile - economics ; Arthritis, Juvenile - genetics ; Arthritis, Juvenile - immunology ; Autoantibodies - metabolism ; Biopsy ; Celiac disease ; Celiac Disease - diagnosis ; Celiac Disease - economics ; Celiac Disease - genetics ; Celiac Disease - immunology ; Child ; Child, Preschool ; Children ; Children & youth ; Complications and side effects ; Cost-Benefit Analysis ; Early Diagnosis ; Environmental Influences ; Female ; Gastroenterology ; Genotype ; Genotype & phenotype ; Genotypes ; Genotyping ; Genotyping Techniques - economics ; Genotyping Techniques - methods ; Guidelines ; Health aspects ; Histocompatibility antigen HLA ; HLA-DQ Antigens - genetics ; Humans ; Infant ; Intestine ; Juvenile arthritis ; Male ; Medical screening ; Nutrition ; Patients ; Prospective Studies ; Rheumatoid arthritis ; Risk factors ; Screening Tests ; Statistical Analysis</subject><ispartof>Archives of disease in childhood, 2017-07, Vol.102 (7), p.607-611</ispartof><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing</rights><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.</rights><rights>Copyright: 2017 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b458t-747d6e3e6120be635377cfa9c7ea69ffefee44cd839176b7975bdcd13d5a665d3</citedby><cites>FETCH-LOGICAL-b458t-747d6e3e6120be635377cfa9c7ea69ffefee44cd839176b7975bdcd13d5a665d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1912450940/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1912450940?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,21376,21392,27922,27923,33609,33610,33875,33876,43731,43878,73991,74167</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28232458$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Skrabl-Baumgartner, Andrea</creatorcontrib><creatorcontrib>Christine Hauer, Almuthe</creatorcontrib><creatorcontrib>Erwa, Wolfgang</creatorcontrib><creatorcontrib>Jahnel, Jörg</creatorcontrib><title>HLA genotyping as first-line screening tool for coeliac disease in children with juvenile idiopathic arthritis</title><title>Archives of disease in childhood</title><addtitle>Arch Dis Child</addtitle><description>ObjectivesCoeliac disease (CD) and juvenile idiopathic arthritis (JIA) often coexist. This association warrants assessment for CD in patients with JIA. We evaluated the clinical relevance and cost-effectiveness of human leucocyte antigen (HLA) genotyping in first-line screening for development of CD in children with JIA.Patients and interventions95 patients with JIA were screened for CD using CD-specific antibodies. In case of positivity, a small intestinal biopsy was performed to confirm diagnosis. In addition, HLA genotyping was performed. 110 age-matched and sex-matched Caucasian children from the same geographical area served as controls.ResultsCD was diagnosed in 4 of 95 patients with JIA (4.2%), a rate significantly higher compared with controls (p<0.02) and 14 times higher than in the general population. Twenty-six patients (27.4%) had one of the variants of the risk genotypes. All four patients diagnosed with CD had a HLA-DQ2.5 genotype: one was homozygote, the remainder heterozygote. Twenty-two patients are, judging by their HLA genotypes, at risk of developing CD and require repeated serological screening. None of the 69 patients without HLA-DQ2/DQ8 genotypes had CD-specific antibodies. Screening with HLA genotyping becomes cheaper than screening without after the second determination.ConclusionsIn our cohort of patients with JIA, lack of HLA-DQ2/DQ8 genotypes identified a majority not at risk of CD in whom repeated serological testing is unnecessary. Genotyping is nowadays the most efficient and cost-effective way to screen for CD risk in JIA.</description><subject>Adolescent</subject><subject>Age of Onset</subject><subject>Antibodies</subject><subject>Antigens</subject><subject>Arthritis</subject><subject>Arthritis, Juvenile - economics</subject><subject>Arthritis, Juvenile - genetics</subject><subject>Arthritis, Juvenile - immunology</subject><subject>Autoantibodies - metabolism</subject><subject>Biopsy</subject><subject>Celiac disease</subject><subject>Celiac Disease - diagnosis</subject><subject>Celiac Disease - economics</subject><subject>Celiac Disease - genetics</subject><subject>Celiac Disease - immunology</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>Children & youth</subject><subject>Complications and side effects</subject><subject>Cost-Benefit Analysis</subject><subject>Early Diagnosis</subject><subject>Environmental Influences</subject><subject>Female</subject><subject>Gastroenterology</subject><subject>Genotype</subject><subject>Genotype & phenotype</subject><subject>Genotypes</subject><subject>Genotyping</subject><subject>Genotyping Techniques - economics</subject><subject>Genotyping Techniques - methods</subject><subject>Guidelines</subject><subject>Health aspects</subject><subject>Histocompatibility antigen HLA</subject><subject>HLA-DQ Antigens - genetics</subject><subject>Humans</subject><subject>Infant</subject><subject>Intestine</subject><subject>Juvenile arthritis</subject><subject>Male</subject><subject>Medical screening</subject><subject>Nutrition</subject><subject>Patients</subject><subject>Prospective Studies</subject><subject>Rheumatoid arthritis</subject><subject>Risk factors</subject><subject>Screening Tests</subject><subject>Statistical Analysis</subject><issn>0003-9888</issn><issn>1468-2044</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>ALSLI</sourceid><sourceid>CJNVE</sourceid><sourceid>M0P</sourceid><recordid>eNqNkU-P0zAQxSMEYrsLXwFZ4sIlix3_zbGqgEWqtBc4W44zaVy5drEdYL89LlkQ4gInS-Pfm3kzr2kQwbeEUPHWJDuPLtvZ-bHtMBEtJYQz9qTZECZULTH2tNlgjGnbK6WumuucjxiTTin6vLnqVEc7xtWmCXf7LTpAiOXh7MIBmYwml3JpvQuAsk0A4VIvMXo0xYRsBO-MRXU8mAzIBfTTRoKAvrkyo-PytUp8_RldPJsyO4tMKnNyxeUXzbPJ-AwvH9-b5vP7d592d-3-_sPH3XbfDtVVaSWTowAKgnR4AEE5ldJOprcSjOinCSYAxuyoaE-kGGQv-TDakdCRGyH4SG-aN2vfc4pfFshFn-q5wHsTIC5Zk54IKhXh8t-okh2XUkla0dd_oce4pFAXuTSsB8U9w5VqV-pgPGgXbAwFvhcbvYcD6Lrn7l5vORY96TnmlVcrb1PMOcGkz8mdTHrQBOtL3PrPuPUlbr3GXaWvHg0twwnG38Jf-VaArsBwOv5_2x_657p3</recordid><startdate>20170701</startdate><enddate>20170701</enddate><creator>Skrabl-Baumgartner, Andrea</creator><creator>Christine Hauer, Almuthe</creator><creator>Erwa, Wolfgang</creator><creator>Jahnel, Jörg</creator><general>BMJ Publishing Group Ltd</general><general>BMJ Publishing Group LTD</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88B</scope><scope>88E</scope><scope>88I</scope><scope>8A4</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>CJNVE</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0P</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEDU</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20170701</creationdate><title>HLA genotyping as first-line screening tool for coeliac disease in children with juvenile idiopathic arthritis</title><author>Skrabl-Baumgartner, Andrea ; Christine Hauer, Almuthe ; Erwa, Wolfgang ; Jahnel, Jörg</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b458t-747d6e3e6120be635377cfa9c7ea69ffefee44cd839176b7975bdcd13d5a665d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adolescent</topic><topic>Age of Onset</topic><topic>Antibodies</topic><topic>Antigens</topic><topic>Arthritis</topic><topic>Arthritis, Juvenile - economics</topic><topic>Arthritis, Juvenile - genetics</topic><topic>Arthritis, Juvenile - immunology</topic><topic>Autoantibodies - metabolism</topic><topic>Biopsy</topic><topic>Celiac disease</topic><topic>Celiac Disease - diagnosis</topic><topic>Celiac Disease - economics</topic><topic>Celiac Disease - genetics</topic><topic>Celiac Disease - immunology</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>Children & youth</topic><topic>Complications and side effects</topic><topic>Cost-Benefit Analysis</topic><topic>Early Diagnosis</topic><topic>Environmental Influences</topic><topic>Female</topic><topic>Gastroenterology</topic><topic>Genotype</topic><topic>Genotype & phenotype</topic><topic>Genotypes</topic><topic>Genotyping</topic><topic>Genotyping Techniques - economics</topic><topic>Genotyping Techniques - methods</topic><topic>Guidelines</topic><topic>Health aspects</topic><topic>Histocompatibility antigen HLA</topic><topic>HLA-DQ Antigens - genetics</topic><topic>Humans</topic><topic>Infant</topic><topic>Intestine</topic><topic>Juvenile arthritis</topic><topic>Male</topic><topic>Medical screening</topic><topic>Nutrition</topic><topic>Patients</topic><topic>Prospective Studies</topic><topic>Rheumatoid arthritis</topic><topic>Risk factors</topic><topic>Screening Tests</topic><topic>Statistical Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Skrabl-Baumgartner, Andrea</creatorcontrib><creatorcontrib>Christine Hauer, Almuthe</creatorcontrib><creatorcontrib>Erwa, Wolfgang</creatorcontrib><creatorcontrib>Jahnel, Jörg</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Education Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>Education Periodicals</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>Social Science Premium Collection</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Education Collection</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Education Database</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>ProQuest One Education</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Archives of disease in childhood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Skrabl-Baumgartner, Andrea</au><au>Christine Hauer, Almuthe</au><au>Erwa, Wolfgang</au><au>Jahnel, Jörg</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HLA genotyping as first-line screening tool for coeliac disease in children with juvenile idiopathic arthritis</atitle><jtitle>Archives of disease in childhood</jtitle><addtitle>Arch Dis Child</addtitle><date>2017-07-01</date><risdate>2017</risdate><volume>102</volume><issue>7</issue><spage>607</spage><epage>611</epage><pages>607-611</pages><issn>0003-9888</issn><eissn>1468-2044</eissn><abstract>ObjectivesCoeliac disease (CD) and juvenile idiopathic arthritis (JIA) often coexist. This association warrants assessment for CD in patients with JIA. We evaluated the clinical relevance and cost-effectiveness of human leucocyte antigen (HLA) genotyping in first-line screening for development of CD in children with JIA.Patients and interventions95 patients with JIA were screened for CD using CD-specific antibodies. In case of positivity, a small intestinal biopsy was performed to confirm diagnosis. In addition, HLA genotyping was performed. 110 age-matched and sex-matched Caucasian children from the same geographical area served as controls.ResultsCD was diagnosed in 4 of 95 patients with JIA (4.2%), a rate significantly higher compared with controls (p<0.02) and 14 times higher than in the general population. Twenty-six patients (27.4%) had one of the variants of the risk genotypes. All four patients diagnosed with CD had a HLA-DQ2.5 genotype: one was homozygote, the remainder heterozygote. Twenty-two patients are, judging by their HLA genotypes, at risk of developing CD and require repeated serological screening. None of the 69 patients without HLA-DQ2/DQ8 genotypes had CD-specific antibodies. Screening with HLA genotyping becomes cheaper than screening without after the second determination.ConclusionsIn our cohort of patients with JIA, lack of HLA-DQ2/DQ8 genotypes identified a majority not at risk of CD in whom repeated serological testing is unnecessary. Genotyping is nowadays the most efficient and cost-effective way to screen for CD risk in JIA.</abstract><cop>England</cop><pub>BMJ Publishing Group Ltd</pub><pmid>28232458</pmid><doi>10.1136/archdischild-2016-311544</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-9888 |
ispartof | Archives of disease in childhood, 2017-07, Vol.102 (7), p.607-611 |
issn | 0003-9888 1468-2044 |
language | eng |
recordid | cdi_proquest_miscellaneous_1916378157 |
source | Social Science Premium Collection; Education Collection |
subjects | Adolescent Age of Onset Antibodies Antigens Arthritis Arthritis, Juvenile - economics Arthritis, Juvenile - genetics Arthritis, Juvenile - immunology Autoantibodies - metabolism Biopsy Celiac disease Celiac Disease - diagnosis Celiac Disease - economics Celiac Disease - genetics Celiac Disease - immunology Child Child, Preschool Children Children & youth Complications and side effects Cost-Benefit Analysis Early Diagnosis Environmental Influences Female Gastroenterology Genotype Genotype & phenotype Genotypes Genotyping Genotyping Techniques - economics Genotyping Techniques - methods Guidelines Health aspects Histocompatibility antigen HLA HLA-DQ Antigens - genetics Humans Infant Intestine Juvenile arthritis Male Medical screening Nutrition Patients Prospective Studies Rheumatoid arthritis Risk factors Screening Tests Statistical Analysis |
title | HLA genotyping as first-line screening tool for coeliac disease in children with juvenile idiopathic arthritis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T21%3A14%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HLA%20genotyping%20as%20first-line%20screening%20tool%20for%20coeliac%20disease%20in%20children%20with%20juvenile%20idiopathic%20arthritis&rft.jtitle=Archives%20of%20disease%20in%20childhood&rft.au=Skrabl-Baumgartner,%20Andrea&rft.date=2017-07-01&rft.volume=102&rft.issue=7&rft.spage=607&rft.epage=611&rft.pages=607-611&rft.issn=0003-9888&rft.eissn=1468-2044&rft_id=info:doi/10.1136/archdischild-2016-311544&rft_dat=%3Cgale_proqu%3EA506919505%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b458t-747d6e3e6120be635377cfa9c7ea69ffefee44cd839176b7975bdcd13d5a665d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1912450940&rft_id=info:pmid/28232458&rft_galeid=A506919505&rfr_iscdi=true |